Site Members can sign up for company wide alerts
Lawsuit Overview
An investor in King Pharmaceuticals, Inc. (NYSE:KG) filed a lawsuit in State Court against King Chairman and CEO, King directors and others alleging breaches of fiduciary duties arising out of their attempt to sell King Pharmaceuticals too cheaply via an unfair process to Pfizer Inc. According to the complaint the plaintiff alleges that King Pharmaceuticals Chairman and CEO and its B...
You must register (for free) or login to view the entire case.